Direktorat Registrasi ObatValid

DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE & SODIUM PHOSPHATE MONOBASIC MONOHYDRATE

Claim this product
BPOM Number
GKL2638202935A1
Approved
29 July 2026
Expiry
29 July 2031
Form
LARUTAN ORAL

About This Registration

DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE & SODIUM PHOSPHATE MONOBASIC MONOHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2638202935A1. Its current registration status is Valid, with the licence valid until 29 July 2031. The product is registered to PHARMA HEALTH CARE - INDONESIA. BPOM first approved this registration in July 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 30 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 1 BOTOL PLASTIK @ 45 ML
Department
Direktorat Registrasi Obat
Data Last Updated
30 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (3)

DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE<BR>SODIUM PHOSPHATE MONOBASIC MONOHYDRATE

Market Intelligence

Manufacturer Scale
PHARMA HEALTH CARE - INDONESIA produces 16 registered products
Registration Age
Registered for 1 month
Update Status
Recently updated (34 days ago)

FDA Cross-Reference

via openFDA
Generic Name
DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from PHARMA HEALTH CARE - INDONESIA

DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE & SODIUM PHOSPHATE MONOBASIC MONOHYDRATE

-GKL2638202935A1
Valid
Approved: Jul 29, 2026LARUTAN ORAL
View product →

Products in the same class

VONOPRAZAN FUMARATE

-GKL2643506217A1
Valid
Approved: Mar 29, 2026TABLET SALUT SELAPUT
AMAROX PHARMA GLOBAL - INDONESIA
View product →

PROMAG PROGERD

-DTL2611649233A1
Valid
Approved: Mar 16, 2026SUSPENSI
KALBE FARMA - INDONESIA
View product →

GLIVEC

-DKI2121001417A1
Valid
Approved: Feb 27, 2026TABLET SALUT SELAPUT
NOVARTIS INDONESIA - INDONESIA
View product →

VOLA

-DKL2606324633A1
Valid
Approved: Jan 27, 2026SUSPENSI
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
View product →

STABACTAM

-DKL0431524844A1
Valid
Approved: Jan 27, 2026SERBUK INJEKSI
PRATAPA NIRMALA - INDONESIA
View product →
1